Wells Fargo
TARO

Wells Fargo’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Wells Fargo’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,578
Closed -$151K – 7662
2024
Q1 		$151K Buy
3,578
+818
+30% +$34.5K ﹤0.01% 4646
2023
Q4 		$115K Buy
2,760
+489
+22% +$18K ﹤0.01% 4816
2023
Q3 		$85.6K Sell
2,271
-785
-26% -$29.5K ﹤0.01% 4869
2023
Q2 		$116K Buy
+3,056
New +$95.9K ﹤0.01% 4946
2022
Q4 		– Sell
-118
Closed -$4K – 7803
2022
Q3 		$4K Sell
118
-1,807
-94% -$62.3K ﹤0.01% 6005
2022
Q2 		$70K Sell
1,925
-387
-17% -$14.8K ﹤0.01% 4856
2022
Q1 		$100K Sell
2,312
-1,590
-41% -$74.3K ﹤0.01% 5334
2021
Q4 		$195K Sell
3,902
-1,117
-22% -$62.6K ﹤0.01% 5281
2021
Q3 		$319K Buy
5,019
+522
+12% +$36.1K ﹤0.01% 4902
2021
Q2 		$324K Sell
4,497
-858
-16% -$63K ﹤0.01% 4829
2021
Q1 		$394K Buy
5,355
+272
+5% +$20.7K ﹤0.01% 4817
2020
Q4 		$373K Sell
5,083
-283
-5% -$18.2K ﹤0.01% 4738
2020
Q3 		$294K Buy
5,366
+3,979
+287% +$248K ﹤0.01% 4732
2020
Q2 		$93K Sell
1,387
-203
-13% -$13.6K ﹤0.01% 5257
2020
Q1 		$98K Sell
1,590
-650
-29% -$48.2K ﹤0.01% 5074
2019
Q4 		$197K Buy
2,240
+1,656
+284% +$140K ﹤0.01% 4959
2019
Q3 		$44K Buy
584
+14
+2% +$1.14K ﹤0.01% 5596
2019
Q2 		$49K Sell
570
-1,212
-68% -$120K ﹤0.01% 5558
2019
Q1 		$192K Buy
1,782
+1,207
+210% +$120K ﹤0.01% 4846
2018
Q4 		$49K Sell
575
-66
-10% -$6.36K ﹤0.01% 5525
2018
Q3 		$63K Buy
641
+10
+2% +$1.08K ﹤0.01% 5522
2018
Q2 		$73K Buy
631
+3
+0.5% +$330 ﹤0.01% 5494
2018
Q1 		$62K Buy
628
+29
+5% +$2.94K ﹤0.01% 5493
2017
Q4 		$63K Sell
599
-1,134
-65% -$125K ﹤0.01% 5476
2017
Q3 		$196K Buy
1,733
+48
+3% +$5.22K ﹤0.01% 4938
2017
Q2 		$189K Buy
1,685
+170
+11% +$19.2K ﹤0.01% 4823
2017
Q1 		$176K Sell
1,515
-468
-24% -$51.8K ﹤0.01% 4889
2016
Q4 		$209K Buy
1,983
+292
+17% +$30.6K ﹤0.01% 4742
2016
Q3 		$187K Sell
1,691
-189
-10% -$25K ﹤0.01% 4521
2016
Q2 		$274K Sell
1,880
-901
-32% -$128K ﹤0.01% 4237
2016
Q1 		$399K Sell
2,781
-2,045
-42% -$290K ﹤0.01% 4006
2015
Q4 		$746K Sell
4,826
-288
-6% -$42K ﹤0.01% 3664
2015
Q3 		$731K Sell
5,114
-3,907
-43% -$546K ﹤0.01% 3702
2015
Q2 		$1.3M Buy
9,021
+557
+7% +$79.4K ﹤0.01% 3411
2015
Q1 		$1.19M Buy
8,464
+5,306
+168% +$817K ﹤0.01% 3406
2014
Q4 		$468K Buy
3,158
+346
+12% +$50.8K ﹤0.01% 3984
2014
Q3 		$433K Buy
2,812
+2,712
+2,712% +$408K ﹤0.01% 3974
2014
Q2 		$14K Sell
100
-542
-84% -$60.2K ﹤0.01% 5526
2014
Q1 		$71K Sell
642
-653
-50% -$71.1K ﹤0.01% 4806
2013
Q4 		$128K Buy
1,295
+345
+36% +$29.9K ﹤0.01% 4442
2013
Q3 		$72K Buy
950
+298
+46% +$19.3K ﹤0.01% 4576
2013
Q2 		$37K Buy
+652
New +$38.5K ﹤0.01% 4690

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $10.6B AUM 19.99% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Wells Fargo's TARO Position: Q2 2024 in Review

Wells Fargo sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 3,578 shares — an estimated $151K sold.

Wells Fargo first reported a position in TARO in Q2 2013 and held it in 42 quarters. The position peaked at $1.3M in Q2 2015. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Wells Fargo reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 3,578 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $151K.
  • Wells Fargo first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 42 quarters.
  • Wells Fargo's Taro Pharmaceutical Industries Ltd. position peaked at $1.3M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.